Search

Djamal I Bouzida

from San Diego, CA
Age ~61

Djamal Bouzida Phones & Addresses

  • 4285 Corte Favor, San Diego, CA 92130 (858) 794-8984
  • Somerville, MA
  • San Jose, CA
  • Pittsburgh, PA
  • Auburndale, MA

Work

Company: Visionary pharmaceuticals, inc. 2011 Position: Director, lead discovery

Education

School / High School: Carnegie Mellon University

Skills

Drug Discovery • Biotechnology • Lifesciences • Cheminformatics • Oncology • Computational Chemistry • Drug Design • Drug Development • Pharmaceutical Industry • Lead Change • Clinical Research • Medicinal Chemistry

Emails

Industries

Biotechnology

Resumes

Resumes

Djamal Bouzida Photo 1

Director, Lead Discovery

View page
Position:
Director, Lead Discovery at Visionary Pharmaceuticals, Inc.
Location:
Greater San Diego Area
Industry:
Biotechnology
Work:
Visionary Pharmaceuticals, Inc. since 2011
Director, Lead Discovery

Agouron/Pfizer - San Diego 1996 - 2010
Senior Principal Scientist

IBM 1994 - 1995
Advisory Scientist/Engineer

Boston University - Biomedical Engineering - Greater Boston Area 1991 - 1993
Postdoctoral Fellow
Education:
Carnegie Mellon University
Skills:
Drug Discovery
Biotechnology
Lifesciences
Cheminformatics
Oncology
Computational Chemistry
Drug Design
Drug Development
Pharmaceutical Industry
Lead Change
Clinical Research
Medicinal Chemistry

Publications

Us Patents

Pyrrolopyrazoles, Potent Kinase Inhibitors

View page
US Patent:
8530652, Sep 10, 2013
Filed:
Oct 6, 2011
Appl. No.:
13/267302
Inventors:
Junhu Zhang - San Diego CA, US
Chuangxing Guo - San Diego CA, US
Djamal Bouzida - San Diego CA, US
Liming Dong - San Diego CA, US
Haitao Li - San Diego CA, US
Joseph Timothy Marakovits - Encinitas CA, US
Anle Yang - San Diego CA, US
Yufeng Hong - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
Pfizer Inc. - New York NY
International Classification:
C07D 491/00
A01N 43/90
US Classification:
544278, 5142601
Abstract:
Pyrrole pyrazole compounds of formula I, compositions including these compounds and methods of their use are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as inhibitors of PAK4.

Pyrrolopyrazole, Potent Kinase Inhibitors

View page
US Patent:
20100222342, Sep 2, 2010
Filed:
Dec 28, 2005
Appl. No.:
11/813658
Inventors:
Junhu Zhang - San Diego CA, US
Chuangxing Guo - San Diego CA, US
Djamal Bouzida - San Diego CA, US
Liming Dong - San Diego CA, US
Haitao Li - San Diego CA, US
Joseph Timothy Marakovits - Encinitas CA, US
Anle Yang - San Diego CA, US
Yufeng Hong - San Diego CA, US
International Classification:
A61K 31/5377
C07D 495/04
A61K 31/519
C07D 403/14
A61K 31/506
A61K 31/53
C07D 239/47
C07D 401/14
A61K 31/4439
C07D 413/14
C07D 491/048
A61K 31/517
A61P 35/00
US Classification:
5142342, 544278, 5142601, 544328, 514256, 544207, 514245, 544317, 514274, 544211, 5462757, 514338, 544122, 544284, 5142641
Abstract:
Pyrrole pyrazole compounds of formula I, compositions including these compounds and methods of their use are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as inhibitors of PAK4.
Djamal I Bouzida from San Diego, CA, age ~61 Get Report